outfox

Funds / institutions · SEC Form 13F

What institutions reported holding

Search 381,214 reported position rows across 20 reporting entities and their collected quarters. Explore the holdings behind the names.

Collection dates and how to read these holdings

Partial manager coverage. Form 13F reports quarter-end holdings, usually filed later; not exact trades, transaction dates, current portfolios or ETF constituent data. Short positions, some securities, confidential holdings and unreviewed amendments may be absent. CUSIP and issuer names are preserved as filed; ticker/issuer-CIK matching is not inferred. Values use the SEC filing-date format (USD from January 3, 2023; thousands of USD before). Available valid filings are searchable even without comparison quarters. Combination reports and confidential-omission flags describe incomplete reported portfolios; only disclosed positions are shown, with no inferred missing holdings. Separate reporting entities remain separate. The latest quarter is partial as filings arrive; earlier reviewed snapshots remain searchable.

51 source-checked filings. A reported portfolio snapshot—not executed trades. Histories may be incomplete; missing data does not mean no holdings. Featured investor names identify associated management firms, not personal portfolios.

  • Third Point LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:43.118Z
  • APPALOOSA LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:41.303Z
  • VANGUARD GROUP INC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:55.910Z
  • TWO SIGMA INVESTMENTS, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:27.467Z
  • Pershing Square Capital Management, L.P.: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:37.679Z
  • STATE STREET CORP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:58.075Z
  • COATUE MANAGEMENT LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:31.488Z
  • TIGER GLOBAL MANAGEMENT LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:33.886Z
  • RENAISSANCE TECHNOLOGIES LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:25.387Z
  • GOLDMAN SACHS GROUP INC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:08.805Z
  • Bridgewater Associates, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:29.574Z
  • Duquesne Family Office LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:45.054Z
  • JPMORGAN CHASE & CO: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:03.721Z
  • TCI FUND MANAGEMENT LTD: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:46.863Z
  • PERSHING SQUARE INC.: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:39.481Z
  • Altimeter Capital Management, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:35.674Z
  • MORGAN STANLEY: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:12.934Z
  • FMR LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:00.998Z
  • Berkshire Hathaway Inc: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:54.052Z
  • CITADEL ADVISORS LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:21.575Z
  • RENAISSANCE TECHNOLOGIES LLC: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:59.260Z
  • MORGAN STANLEY: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:53.319Z
  • STATE STREET CORP: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:33.733Z
  • JPMORGAN CHASE & CO: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:48.410Z

Reported positions

381,214 matching source rows · Page 755 of 15,249. A security can appear in multiple quarters or reporting entities.

JANUS LIVING INC

COMMON · CUSIP 471024109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$4,860,650
Reported shares
157078
Source units and reporting details

Value as filed: 4860650 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 130240, shared 0, none 26838.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JANUS LIVING INC

COMMON · CUSIP 471024109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$7,520
Reported shares
251
Source units and reporting details

Value as filed: 7520 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 251, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities plc · 13F file 028-12006

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JANUS LIVING INC

COMMON · CUSIP 471024109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$2,585,069
Reported shares
86284
Source units and reporting details

Value as filed: 2585069 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 86284, shared 0, none 0.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JANUX THERAPEUTICS INC

COMMON · CUSIP 47103J105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$88,598
Reported shares
5227
Source units and reporting details

Value as filed: 88598 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 5227, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities plc · 13F file 028-12006

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JANUX THERAPEUTICS INC

COMMON · CUSIP 47103J105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$455,345
Reported shares
26864
Source units and reporting details

Value as filed: 455345 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 4238, shared 0, none 22626.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JANUX THERAPEUTICS INC

COMMON · CUSIP 47103J105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$685,628
Reported shares
40450
Source units and reporting details

Value as filed: 685628 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 40450.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JANUX THERAPEUTICS INC

COMMON · CUSIP 47103J105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,716,526
Reported shares
101270
Source units and reporting details

Value as filed: 1716526 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 93663, shared 0, none 7607.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JASPER THERAPEUTICS INC

COMMON · CUSIP 471871202

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$92,522
Reported shares
147940
Source units and reporting details

Value as filed: 92522 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 147940, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JASPER THERAPEUTICS INC

COMMON · CUSIP 471871202

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$6
Reported shares
9
Source units and reporting details

Value as filed: 6 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 9, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities plc · 13F file 028-12006

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JATT III ACQUISITION CORP

COMMON · CUSIP G5080G109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$381
Reported shares
35
Source units and reporting details

Value as filed: 381 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 35, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ INVESTMENTS I LTD

BOND · CUSIP 472145AH4

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,808,667
Reported principal amount
1110000
Source units and reporting details

Value as filed: 1808667 USD. Discretion code: DFND. Filing-local manager numbers: 8. Voting authority: sole 200000, shared 610000, none 300000.

Included managers attributed to this row:

  • JPMorgan Asset Management (UK) Ltd · 13F file 028-11947

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ INVESTMENTS I LTD

BOND · CUSIP 472145AH4

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$12,155,548
Reported principal amount
7460000
Source units and reporting details

Value as filed: 12155548 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 5125000, shared 0, none 2335000.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ INVESTMENTS I LTD

BOND · CUSIP 472145AH4

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$12,867,609
Reported principal amount
7897000
Source units and reporting details

Value as filed: 12867609 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 7897000, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ PHARMACEUTICALS PLC

COMMON · CUSIP G50871105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—other. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,575
Reported shares
6
Source units and reporting details

Value as filed: 1575 USD. Discretion code: OTR. Filing-local manager numbers: 23. Voting authority: sole 0, shared 0, none 6.

Included managers attributed to this row:

  • 55I, LLC · 13F file 028-19649

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ PHARMACEUTICALS PLC

COMMON · CUSIP G50871105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—other. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$4,647
Reported shares
20
Source units and reporting details

Value as filed: 4647 USD. Discretion code: OTR. Filing-local manager numbers: 1. Voting authority: sole 0, shared 0, none 20.

Included managers attributed to this row:

  • J.P. Morgan Trust Co of Delaware · 13F file 028-12125

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ PHARMACEUTICALS PLC

COMMON · CUSIP G50871105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$16,248,212
Reported shares
69929
Source units and reporting details

Value as filed: 16248212 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 8467, shared 0, none 61462.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ PHARMACEUTICALS PLC

COMMON · CUSIP G50871105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$19,692,527
Reported shares
84753
Source units and reporting details

Value as filed: 19692527 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 84753.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ PHARMACEUTICALS PLC

COMMON · CUSIP G50871105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$199,256,559
Reported shares
853936
Source units and reporting details

Value as filed: 199256559 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 800192, shared 0, none 53744.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ PHARMACEUTICALS PLC

COMMON · CUSIP G50871105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,626
Reported shares
7
Source units and reporting details

Value as filed: 1626 USD. Discretion code: DFND. Filing-local manager numbers: 23. Voting authority: sole 7, shared 0, none 0.

Included managers attributed to this row:

  • 55I, LLC · 13F file 028-19649

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ PHARMACEUTICALS PLC

COMMON · CUSIP G50871105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$2,324
Reported shares
10
Source units and reporting details

Value as filed: 2324 USD. Discretion code: DFND. Filing-local manager numbers: 1. Voting authority: sole 0, shared 0, none 10.

Included managers attributed to this row:

  • J.P. Morgan Trust Co of Delaware · 13F file 028-12125

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ PHARMACEUTICALS PLC

COMMON · CUSIP G50871105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$80,393
Reported shares
346
Source units and reporting details

Value as filed: 80393 USD. Discretion code: DFND. Filing-local manager numbers: 24. Voting authority: sole 346, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan SE · 13F file 028-23287

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ PHARMACEUTICALS PLC

COMMON · CUSIP G50871105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$161,948
Reported shares
697
Source units and reporting details

Value as filed: 161948 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 697, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities plc · 13F file 028-12006

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JAZZ PHARMACEUTICALS PLC

COMMON · CUSIP G50871105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,178,015
Reported shares
5070
Source units and reporting details

Value as filed: 1178015 USD. Discretion code: DFND. Filing-local manager numbers: 8. Voting authority: sole 5070, shared 0, none 0.

Included managers attributed to this row:

  • JPMorgan Asset Management (UK) Ltd · 13F file 028-11947

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JBG SMITH PPTYS

COMMON · CUSIP 46590V100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$765,994
Reported shares
75841
Source units and reporting details

Value as filed: 765994 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 47648, shared 0, none 28193.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

JBG SMITH PPTYS

COMMON · CUSIP 46590V100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$6,747
Reported shares
668
Source units and reporting details

Value as filed: 6747 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 668, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities plc · 13F file 028-12006

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗